Today marks 4 months since we received 201 topline results, ~6 months since end of trial, the further analyses must be coming along nicely.
Not sure it has been pointed out but all the posters and presentation from the MSA congress are available on Alterity website Science section. In the presentation they highlight the severe OH of the 75mg group. I don't recall them highlighting this in previous presentation (??) so perhaps it's developed as their leading theory on the difference between 50 vs 75mg group performance. Would be great to hear Stamler talk on this and get company's views if dosage window also playing a part. Also a lot to digest in the MSA-AI poster.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)